NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells

Alessandra Mangolini, Marco Bogo, Chiara Durante, Monica Borgatti, Roberto Gambari, Peter C Harris, Rosario Rizzuto, Paolo Pinton, Gianluca Aguiari, Laura Del Senno

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, a gene encoding fibrocystin/polyductin (FC1), a membrane-associated receptor-like protein involved in the regulation of tubular cell adhesion, proliferation and apoptosis. Although it is generally accepted that apoptosis is implicated in ARPKD, the question of whether increased apoptosis is a normal response to abnormal cell proliferation or, instead, it is a primary event, is still subject to debate. In support of the latter hypothesis, we hereby provide evidence that apoptosis occurs in the absence of hyper-proliferation of FC1-depleted kidney cells. In fact, a decrease in cell proliferation, with a concomitant increase in apoptotic index and caspase-3 activity was observed in response to FC1-depletion by PKHD1 siRNA silencing in HEK293 and 4/5 tubular cells. FC1-depletion also induced reduction in ERK1/2 kinase activation, upregulation of the pro-apoptotic protein p53 and activation of NF-κB, a transcription factor which reduces apoptosis in many organs and tissues. Interestingly, selective inactivation of NF-κB using either an NF-κB decoy or parthenolide, a blocker of IKK-dependent NF-κB activation, reduced, rather then increased, apoptosis and p53 levels in FC1-depleted cells. Therefore, the proapoptotic function of NF-κB during cell death by FC1-depletion in kidney cells is evident.

Original languageEnglish (US)
Pages (from-to)94-104
Number of pages11
JournalApoptosis
Volume15
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Epithelial Cells
Chemical activation
Apoptosis
Kidney
Autosomal Recessive Polycystic Kidney
Cell Proliferation
Cell proliferation
Apoptosis Regulatory Proteins
Gene encoding
Mitogen-Activated Protein Kinase 3
Cell adhesion
Cell death
Cell Adhesion
Caspase 3
Small Interfering RNA
Cell Death
Transcription Factors
Phosphotransferases
Up-Regulation
Tissue

Keywords

  • Apoptosis
  • Autosomal recessive polycystic kidney disease (ARPKD)
  • Fibrocystin
  • Kidney cells
  • NF-κB inhibitors

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Cancer Research
  • Pharmaceutical Science
  • Pharmacology

Cite this

NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells. / Mangolini, Alessandra; Bogo, Marco; Durante, Chiara; Borgatti, Monica; Gambari, Roberto; Harris, Peter C; Rizzuto, Rosario; Pinton, Paolo; Aguiari, Gianluca; Del Senno, Laura.

In: Apoptosis, Vol. 15, No. 1, 01.2010, p. 94-104.

Research output: Contribution to journalArticle

Mangolini, A, Bogo, M, Durante, C, Borgatti, M, Gambari, R, Harris, PC, Rizzuto, R, Pinton, P, Aguiari, G & Del Senno, L 2010, 'NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells', Apoptosis, vol. 15, no. 1, pp. 94-104. https://doi.org/10.1007/s10495-009-0426-7
Mangolini, Alessandra ; Bogo, Marco ; Durante, Chiara ; Borgatti, Monica ; Gambari, Roberto ; Harris, Peter C ; Rizzuto, Rosario ; Pinton, Paolo ; Aguiari, Gianluca ; Del Senno, Laura. / NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells. In: Apoptosis. 2010 ; Vol. 15, No. 1. pp. 94-104.
@article{2d6902ff51ad41feaa4d71c91f244936,
title = "NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells",
abstract = "Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, a gene encoding fibrocystin/polyductin (FC1), a membrane-associated receptor-like protein involved in the regulation of tubular cell adhesion, proliferation and apoptosis. Although it is generally accepted that apoptosis is implicated in ARPKD, the question of whether increased apoptosis is a normal response to abnormal cell proliferation or, instead, it is a primary event, is still subject to debate. In support of the latter hypothesis, we hereby provide evidence that apoptosis occurs in the absence of hyper-proliferation of FC1-depleted kidney cells. In fact, a decrease in cell proliferation, with a concomitant increase in apoptotic index and caspase-3 activity was observed in response to FC1-depletion by PKHD1 siRNA silencing in HEK293 and 4/5 tubular cells. FC1-depletion also induced reduction in ERK1/2 kinase activation, upregulation of the pro-apoptotic protein p53 and activation of NF-κB, a transcription factor which reduces apoptosis in many organs and tissues. Interestingly, selective inactivation of NF-κB using either an NF-κB decoy or parthenolide, a blocker of IKK-dependent NF-κB activation, reduced, rather then increased, apoptosis and p53 levels in FC1-depleted cells. Therefore, the proapoptotic function of NF-κB during cell death by FC1-depletion in kidney cells is evident.",
keywords = "Apoptosis, Autosomal recessive polycystic kidney disease (ARPKD), Fibrocystin, Kidney cells, NF-κB inhibitors",
author = "Alessandra Mangolini and Marco Bogo and Chiara Durante and Monica Borgatti and Roberto Gambari and Harris, {Peter C} and Rosario Rizzuto and Paolo Pinton and Gianluca Aguiari and {Del Senno}, Laura",
year = "2010",
month = "1",
doi = "10.1007/s10495-009-0426-7",
language = "English (US)",
volume = "15",
pages = "94--104",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - NF-κB activation is required for apoptosis in fibrocystin/polyductin- depleted kidney epithelial cells

AU - Mangolini, Alessandra

AU - Bogo, Marco

AU - Durante, Chiara

AU - Borgatti, Monica

AU - Gambari, Roberto

AU - Harris, Peter C

AU - Rizzuto, Rosario

AU - Pinton, Paolo

AU - Aguiari, Gianluca

AU - Del Senno, Laura

PY - 2010/1

Y1 - 2010/1

N2 - Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, a gene encoding fibrocystin/polyductin (FC1), a membrane-associated receptor-like protein involved in the regulation of tubular cell adhesion, proliferation and apoptosis. Although it is generally accepted that apoptosis is implicated in ARPKD, the question of whether increased apoptosis is a normal response to abnormal cell proliferation or, instead, it is a primary event, is still subject to debate. In support of the latter hypothesis, we hereby provide evidence that apoptosis occurs in the absence of hyper-proliferation of FC1-depleted kidney cells. In fact, a decrease in cell proliferation, with a concomitant increase in apoptotic index and caspase-3 activity was observed in response to FC1-depletion by PKHD1 siRNA silencing in HEK293 and 4/5 tubular cells. FC1-depletion also induced reduction in ERK1/2 kinase activation, upregulation of the pro-apoptotic protein p53 and activation of NF-κB, a transcription factor which reduces apoptosis in many organs and tissues. Interestingly, selective inactivation of NF-κB using either an NF-κB decoy or parthenolide, a blocker of IKK-dependent NF-κB activation, reduced, rather then increased, apoptosis and p53 levels in FC1-depleted cells. Therefore, the proapoptotic function of NF-κB during cell death by FC1-depletion in kidney cells is evident.

AB - Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, a gene encoding fibrocystin/polyductin (FC1), a membrane-associated receptor-like protein involved in the regulation of tubular cell adhesion, proliferation and apoptosis. Although it is generally accepted that apoptosis is implicated in ARPKD, the question of whether increased apoptosis is a normal response to abnormal cell proliferation or, instead, it is a primary event, is still subject to debate. In support of the latter hypothesis, we hereby provide evidence that apoptosis occurs in the absence of hyper-proliferation of FC1-depleted kidney cells. In fact, a decrease in cell proliferation, with a concomitant increase in apoptotic index and caspase-3 activity was observed in response to FC1-depletion by PKHD1 siRNA silencing in HEK293 and 4/5 tubular cells. FC1-depletion also induced reduction in ERK1/2 kinase activation, upregulation of the pro-apoptotic protein p53 and activation of NF-κB, a transcription factor which reduces apoptosis in many organs and tissues. Interestingly, selective inactivation of NF-κB using either an NF-κB decoy or parthenolide, a blocker of IKK-dependent NF-κB activation, reduced, rather then increased, apoptosis and p53 levels in FC1-depleted cells. Therefore, the proapoptotic function of NF-κB during cell death by FC1-depletion in kidney cells is evident.

KW - Apoptosis

KW - Autosomal recessive polycystic kidney disease (ARPKD)

KW - Fibrocystin

KW - Kidney cells

KW - NF-κB inhibitors

UR - http://www.scopus.com/inward/record.url?scp=77949261505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949261505&partnerID=8YFLogxK

U2 - 10.1007/s10495-009-0426-7

DO - 10.1007/s10495-009-0426-7

M3 - Article

C2 - 19943112

AN - SCOPUS:77949261505

VL - 15

SP - 94

EP - 104

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 1

ER -